We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
-6.93%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
AUM
$1,000M
AUM Growth
+$239M
Cap. Flow
+$349M
Cap. Flow %
34.94%
Top 10 Hldgs %
8.93%
Holding
1,387
New
562
Increased
225
Reduced
140
Closed
460

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$12M
2
VZ icon
Verizon
VZ
+$11.7M
3
CMCSA icon
Comcast
CMCSA
+$10.3M
4
PG icon
Procter & Gamble
PG
+$7.96M
5
LBRDK icon
Liberty Broadband Class C
LBRDK
+$6.85M

Top Sells

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$8.93M
2
AMGN icon
Amgen
AMGN
+$5.81M
3
COP icon
ConocoPhillips
COP
+$5.66M
4
ILMN icon
Illumina
ILMN
+$5.4M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$5.32M

Sector Composition

Rank Sector Weight
1 Technology 16.44%
2 Consumer Discretionary 11.9%
3 Financials 11.76%
4 Industrials 10.6%
5 Healthcare 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTO icon
1326
ZTO Express
ZTO
$18.2B
-17,313
Closed -$475K
NEUE
1327
DELISTED
NeueHealth
NEUE
-282
Closed -$41K
VRN
1328
DELISTED
Veren
VRN
-82,341
Closed -$585K
XYZ
1329
Block Inc
XYZ
$45.9B
-3,364
Closed -$207K
SGI
1330
Somnigroup International
SGI
$15.1B
-76,880
Closed -$1.64M
LGF.B
1331
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
-14,921
Closed -$132K
CMRX
1332
DELISTED
Chimerix, Inc.
CMRX
-10,072
Closed -$21K
PDCO
1333
DELISTED
Patterson Companies, Inc.
PDCO
-7,413
Closed -$225K
ITCI
1334
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-3,593
Closed -$205K
PTVE
1335
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
-14,529
Closed -$145K
SYRS
1336
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
-1,013
Closed -$10K
CUTR
1337
DELISTED
Cutera, Inc.
CUTR
-6,148
Closed -$231K
B
1338
DELISTED
Barnes Group Inc.
B
-12,226
Closed -$381K
SMAR
1339
DELISTED
Smartsheet Inc.
SMAR
-6,879
Closed -$216K
ITI
1340
DELISTED
Iteris, Inc.
ITI
-17,832
Closed -$52K
SEEL
1341
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
-4
Closed -$11K
SWN
1342
DELISTED
Southwestern Energy Company
SWN
-269,906
Closed -$1.69M
GTHX
1343
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
-17,100
Closed -$84K
ASXC
1344
DELISTED
Asensus Surgical, Inc.
ASXC
-31,620
Closed -$13K
VBIV
1345
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
-1,821
Closed -$44K
WIRE
1346
DELISTED
Encore Wire Corp
WIRE
-3,413
Closed -$355K
DMTK
1347
DELISTED
DermTech, Inc. Common Stock
DMTK
-13,616
Closed -$75K
DCPH
1348
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-18,651
Closed -$245K
ERF
1349
DELISTED
Enerplus Corporation
ERF
-36,462
Closed -$482K
TRVN
1350
DELISTED
Trevena, Inc.
TRVN
-43
Closed -$11K

Similar funds

Y-Intercept (HK)'s Q3 2022 Portfolio in Review

As of Q3 2022, Y-Intercept (HK) held 1,387 positions worth $1,000M, up 31% from $761M the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.

Y-Intercept (HK) deployed $349M of net new capital in Q3 2022, opening 562 new positions and adding to 225 existing holdings. Its largest new stake was Chevron: 78,786 shares worth $11.3M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Marathon Petroleum, an estimated $8.93M trimmed.

  • Y-Intercept (HK)'s largest Q3 2022 buy was Chevron: 78,786 shares worth $11.3M.
  • Y-Intercept (HK) added most to Comcast in Q3 2022, an estimated $10.3M increase.
  • Y-Intercept (HK)'s biggest Q3 2022 reduction was Marathon Petroleum, cutting an estimated $8.93M.
  • Y-Intercept (HK) fully exited Amgen in Q3 2022, selling an estimated $5.81M.
  • Y-Intercept (HK)'s ten largest holdings make up 8.9% of its $1,000M portfolio in Q3 2022.
  • Y-Intercept (HK) opened 562 new positions and closed 460 in Q3 2022.
  • Y-Intercept (HK)'s portfolio value rose 31% quarter-over-quarter to $1,000M.

Based on Y-Intercept (HK)'s 13F filing for Q3 2022, filed 14 Feb 2023.